Bluejay Diagnostics, Inc. (BJDX) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 26 transactions totaling $195.2K, demonstrating a bullish sentiment with $195.2K in net insider flow. The most recent transaction on Dec 13, 2023 involved a purchase of 500 shares valued at $1.6K.
No significant insider buying has been recorded for BJDX in the recent period.
No significant insider selling has been recorded for BJDX in the recent period.
Based on recent SEC filings, insider sentiment for BJDX is bullish with an Insider Alignment Score of 100/100 and a net flow of $195.2K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Bluejay Diagnostics, Inc. (BJDX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading BJDX stock, having executed 26 transactions in the past 90 days. The most active insider is Douglas Clark Wurth (Executive), who has made 3 transactions totaling $124.7K.
Get notified when executives and directors at BJDX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 13, 2023 | Dey Indranil | Executive | Purchase | 500 | $3.27 | $1.6K | |
| Dec 13, 2023 | Dey Svetlana | Executive | Purchase | 500 | $3.07 | $1.5K | |
| Mar 28, 2023 | Dey Indranil | Executive | Award | 2,000 | $0.44 | $880 | |
| Mar 28, 2023 | Dey Indranil | Executive | Purchase | 2,000 | $0.44 | $880 | |
| Mar 27, 2023 | Dey Indranil | Executive | Award | 8,000 | $0.44 | $3.5K | |
| Mar 27, 2023 | Dey Indranil | Executive | Purchase | 8,000 | $0.44 | $3.5K | |
| Mar 24, 2023 | Dey Svetlana | Executive | Award | 10,000 | $0.44 | $4.4K | |
| Mar 24, 2023 | Dey Svetlana | Executive | Purchase | 10,000 | $0.44 | $4.4K | |
| Feb 1, 2023 | Clark Wurth Douglas | Executive | Award | 27,500 | $0.44 | $12.1K | |
| Feb 1, 2023 | S. Zeidman Fred | Executive | Award | 27,500 | $0.44 | $12.1K | |
| Feb 1, 2023 | R. Fisher Kenneth | Executive | Payment | 39,316 | $0.44 | $17.3K | |
| Feb 1, 2023 | R. Fisher Kenneth | Executive | Award | 112,500 | $0.44 | $49.5K | |
| Feb 1, 2023 | Dey Indranil | Executive | Payment | 55,612 | $0.44 | $24.5K | |
| Feb 1, 2023 | Dey Indranil | Executive | Award | 159,090 | $0.44 | $70.0K | |
| Feb 1, 2023 | Dey Svetlana | Executive | Award | 27,500 | $0.44 | $12.1K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 14 | $195.2K | 45.8% |
Award(A) | 10 | $188.8K | 44.3% |
Payment(F) | 2 | $41.8K | 9.8% |
Insiders at Bluejay Diagnostics, Inc. are accumulating shares at an accelerated pace. With 8 insiders making 26 transactions totaling $195.2K in purchases versus $0 in sales, the net buying activity of $195.2K signals strong executive confidence. Douglas Clark Wurth (Executive) leads the buying activity with $124.7K in transactions across all time.